Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Sunshine Biopharma (SBFM) Restructuring Costs: 2010-2025

Historic Restructuring Costs for Sunshine Biopharma (SBFM) over the last 3 years, with Sep 2025 value amounting to $614,661.

  • Sunshine Biopharma's Restructuring Costs rose 15.90% to $614,661 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.3 million, marking a year-over-year increase of 13.15%. This contributed to the annual value of $3.1 million for FY2024, which is 45.17% up from last year.
  • Per Sunshine Biopharma's latest filing, its Restructuring Costs stood at $614,661 for Q3 2025, which was down 23.80% from $806,605 recorded in Q2 2025.
  • In the past 5 years, Sunshine Biopharma's Restructuring Costs registered a high of $925,878 during Q1 2025, and its lowest value of $530,334 during Q3 2024.
  • Moreover, its 3-year median value for Restructuring Costs was $720,297 (2023), whereas its average is $741,389.
  • Examining YoY changes over the last 5 years, Sunshine Biopharma's Restructuring Costs showed a top increase of 25.79% in 2024 and a maximum decrease of 2.55% in 2024.
  • Quarterly analysis of 3 years shows Sunshine Biopharma's Restructuring Costs stood at $720,297 in 2023, then increased by 25.79% to $906,056 in 2024, then rose by 15.90% to $614,661 in 2025.
  • Its Restructuring Costs stands at $614,661 for Q3 2025, versus $806,605 for Q2 2025 and $925,878 for Q1 2025.